THE SCARY TRUTH ABOUT $IREN
1 extracted signal · 1 resolved · 0 still active
Mikele X10 Stocks 4Independent analyst profile- Source published
- 25 Sept 2026, 04:57 UTC
- Recorded by Tahlil Plus
- 25 Sept 2026, 05:02 UTC

AI-generated source summary
The analysis highlights the significant debt burden on IREN, with total debt projected to increase from $990 million by June 30, 2025, to $7.7 billion by June 30, 2026. This substantial increase in debt, coupled with the company's ambitious scaling plans that have not been executed before, presents a major risk. The confirmation for a potential bullish trend requires sites to be approved, powered up, and generating revenue to justify the price targets. Analyst price targets for IREN range from $79 to $100. The current closing price on September 16, 2025, was $42.62. The thesis suggests that despite the high debt, if the company successfully executes its plans and generates revenue, it could reach these higher price targets, indicating a potential shift from a bearish to a bullish outlook, assuming successful execution and market acceptance.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Source processing completed
Source analysis and structured extraction completed.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
Mikele X10 Stocks 4
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.
